Real life clinical outcomes of relapsed/refractory diffuse large B cell lymphoma in the rituximab era: The STRIDER study.
Dogliotti I, Peri V, Clerico M, Vassallo F, Musto D, Mercadante S, Ragaini S, Botto B, Levis M, Novo M, Ghislieri M, Molinaro L, Mortara U, Consoli C, Lonardo A, Bondielli G, Ferrero S, Freilone R, Ricardi U, Bruno B, Cavallo F.
Dogliotti I, et al. Among authors: consoli c.
Cancer Med. 2024 Jul;13(14):e7448. doi: 10.1002/cam4.7448.
Cancer Med. 2024.
PMID: 39030982
Free PMC article.